Literature DB >> 21400531

Metabolomics and surgical oncology: Potential role for small molecule biomarkers.

Vanessa W Davis1, Oliver F Bathe, Daniel E Schiller, Carolyn M Slupsky, Michael B Sawyer.   

Abstract

Metabolomics, the newest of the "omics" sciences, has brought much excitement to the field of oncology as a potential new translational tool capable of bringing the molecular world of cancer care to the bedside. While still early in its development, metabolomics could alter the scope and role of surgery in the multidisciplinary treatment of cancer. This review examines potential roles of metabolomics in areas of early cancer detection, personalized therapeutics and tumorigenesis.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21400531     DOI： 10.1002/jso.21831

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  18 in total

Review 1.  Metabolomics: Applications and Promise in Mycobacterial Disease.

Authors:  Mehdi Mirsaeidi; Mohammad Mehdi Banoei; Brent W Winston; Dean E Schraufnagel
Journal:  Ann Am Thorac Soc       Date:  2015-09

2.  Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.

Authors:  Daniela Rodrigues; Joana Pinto; Ana Margarida Araújo; Sara Monteiro-Reis; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Paula Guedes de Pinho; Márcia Carvalho
Journal:  Metabolomics       Date:  2018-04-17       Impact factor: 4.290

Review 3.  Point-of-care testing in the diagnosis of gastrointestinal cancers: current technology and future directions.

Authors:  Jeremy R Huddy; Melody Z Ni; Sheraz R Markar; George B Hanna
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  Inferring metabolic networks using the Bayesian adaptive graphical lasso with informative priors.

Authors:  Christine Peterson; Marina Vannucci; Cemal Karakas; William Choi; Lihua Ma; Mirjana Maletić-Savatić
Journal:  Stat Interface       Date:  2013-10-01       Impact factor: 0.582

5.  Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.

Authors:  Jeremiah Bowers; Emma Hughes; Nicholas Skill; Mary Maluccio; Daniel Raftery
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-03-02       Impact factor: 3.205

6.  Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: application in sarcoma.

Authors:  Andrew D Kelly; Susanne B Breitkopf; Min Yuan; Jeffrey Goldsmith; Dimitrios Spentzos; John M Asara
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

Review 7.  Metabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolites.

Authors:  Jia Liu; Lawrence Litt; Mark R Segal; Mark J S Kelly; Jeffrey G Pelton; Myungwon Kim
Journal:  Int J Mol Sci       Date:  2011-09-28       Impact factor: 5.923

8.  Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.

Authors:  Juan Yang; Jin Yang; Yan Gao; Lingyu Zhao; Liying Liu; Yannan Qin; Xiaofei Wang; Tusheng Song; Chen Huang
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

Review 9.  Are Volatile Organic Compounds Accurate Markers in the Assessment of Colorectal Cancer and Inflammatory Bowel Diseases? A Review.

Authors:  Filippo Vernia; Marco Valvano; Stefano Fabiani; Gianpiero Stefanelli; Salvatore Longo; Angelo Viscido; Giovanni Latella
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

10.  Discrimination of Basal Cell Carcinoma from Normal Skin Tissue Using High-Resolution Magic Angle Spinning 1H NMR Spectroscopy.

Authors:  Je-Ho Mun; Heonho Lee; Dahye Yoon; Byung-Soo Kim; Moon-Bum Kim; Shukmann Kim
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.